Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma

Haematologica. 2008 Nov;93(11):e66. doi: 10.3324/haematol.13750.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Hepatitis B / drug therapy
  • Hepatitis B / epidemiology*
  • Hepatitis B / prevention & control
  • Hepatitis C / drug therapy
  • Hepatitis C / epidemiology
  • Hepatitis C / prevention & control
  • Humans
  • Immunotherapy
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / immunology*
  • Risk Factors

Substances

  • Antiviral Agents